Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib...

Clinical Cancer Research 2015 / 07 Vol. 21; Iss. 14

Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib (SAR245408/XL147) in Patients with Chronic Lymphocytic Leukemia (CLL) or Relapsed/Refractory Lymphoma

Brown, J. R., Davids, M. S., Rodon, J., Abrisqueta, P., Kasar, S. N., Lager, J., Jiang, J., Egile, C., Awan, F. T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-14-3262
Date:
July, 2015
File:
PDF, 3.39 MB
english, 2015
Conversion to is in progress
Conversion to is failed